|
adolescent |
7 |
|
adult |
7 |
|
aged |
7 |
|
aged, 80 and over |
7 |
|
carcinoma, papillary - genetics - metabolism - pathology |
7 |
|
child |
7 |
|
female |
7 |
|
humans |
7 |
|
male |
7 |
|
middle aged |
7 |
|
reverse transcriptase polymerase chain reaction |
7 |
|
thyroid neoplasms - genetics - metabolism - pathology |
7 |
|
young adult |
7 |
|
alanine |
6 |
|
animals |
6 |
|
case-control studies |
6 |
|
cell proliferation |
6 |
|
cell transformation, neoplastic - genetics - metabolism |
6 |
|
electrophoretic mobility shift assay |
6 |
|
gene expression regulation, neoplastic |
6 |
|
germ-line mutation |
6 |
|
goiter, nodular - genetics - metabolism - pathology |
6 |
|
immunoblotting |
6 |
|
luciferases - diagnostic use |
6 |
|
neoplasm staging |
6 |
|
nuclear proteins - genetics - metabolism |
6 |
|
rats |
6 |
|
signal transduction - genetics |
6 |
|
thyroid gland - cytology - metabolism |
6 |
|
thyroidectomy |
6 |
|
transcription factors - genetics - metabolism |
6 |
|
transcription, genetic |
6 |
|
up-regulation |
6 |
|
valine |
6 |
|
primary hyperparathyroidism |
5 |
|
thyroid nodule |
5 |
|
ablation techniques |
4 |
|
high-intensity focused ultrasound ablation |
4 |
|
interventional ultrasonography |
4 |
|
nodule shrinkage |
4 |
|
papillary thyroid carcinoma |
4 |
|
parathyroidectomy |
4 |
|
thermal ablation |
4 |
|
adenoma - radionuclide imaging - surgery - ultrasonography |
3 |
|
anaplastic thyroid cancer |
3 |
|
calcium blood level |
3 |
|
cell differentiation |
3 |
|
focussed ultrasound |
3 |
|
hyperparathyroidism |
3 |
|
hyperparathyroidism, primary - etiology |
3 |
|
hyperplasia |
3 |
|
minimally invasive parathyroidectomy |
3 |
|
neoplasms, second primary - complications - epidemiology - mortality - radiotherapy |
3 |
|
parathyroid adenoma |
3 |
|
parathyroid hormone blood level |
3 |
|
parathyroid neoplasms - radionuclide imaging - surgery - ultrasonography |
3 |
|
postoperative period |
3 |
|
radiotherapy |
3 |
|
retrospective studies |
3 |
|
surgery |
3 |
|
tc99m-sestamibi scintigraphy |
3 |
|
technetium tc 99m sestamibi |
3 |
|
thyroid neoplasms - complications - epidemiology - mortality - pathology - radiotherapy - secondary - surgery |
3 |
|
treatment outcome |
3 |
|
ultrasonography |
3 |
|
young age |
3 |
|
adenocarcinoma, follicular - genetics - metabolism - pathology |
2 |
|
adenocarcinoma, papillary - blood |
2 |
|
benign thyroid nodule |
2 |
|
cost-effectiveness analysis |
2 |
|
cyclin-dependent kinase inhibitor p16 - genetics - metabolism |
2 |
|
differentiated thyroid carcinoma |
2 |
|
dna methylation |
2 |
|
dna, neoplasm - genetics - metabolism |
2 |
|
endocrine ophthalmopathy |
2 |
|
expression |
2 |
|
fine-needle aspiration |
2 |
|
fluorocholine |
2 |
|
fluorodeoxyglucose |
2 |
|
focused ultrasound |
2 |
|
follicular thyroid carcinoma |
2 |
|
graves' disease |
2 |
|
graves’ disease |
2 |
|
hypoparathyroidism |
2 |
|
immunoenzyme techniques |
2 |
|
liver metastasis |
2 |
|
methylation |
2 |
|
neoplasm metastasis |
2 |
|
neoplasm recurrence, local - blood |
2 |
|
neuroendocrine tumor |
2 |
|
nodular goiter |
2 |
|
p16 |
2 |
|
pancreas |
2 |
|
pancreatectomy |
2 |
|
parathyroid neoplasm |
2 |
|
positron emission tomography |
2 |
|
promoter regions, genetic |
2 |
|
qalys |
2 |
|
randomized controlled trial |
2 |
|
recurrent laryngeal nerve |
2 |
|
relapse |
2 |
|
risk stratification |
2 |
|
rna, messenger - genetics - metabolism |
2 |
|
staging |
2 |
|
surveillance |
2 |
|
thyroid carcinoma |
2 |
|
thyroid incidentaloma |
2 |
|
thyroid neoplasms - blood |
2 |
|
thyroid neoplasms - mortality - pathology - surgery |
2 |
|
thyroid neoplasms - pathology - therapy |
2 |
|
thyrotoxicosis |
2 |
|
tumor markers, biological - blood |
2 |
|
ultrasound imaging |
2 |
|
vascular endothelial growth factor a - blood |
2 |
|
vascular endothelial growth factor c - blood |
2 |
|
vocal cord palsy |
2 |
|
abdominal wall - blood supply |
1 |
|
academic medical centers |
1 |
|
adenocarcinoma - pathology - secondary - therapy |
1 |
|
adenocarcinoma, follicular - pathology - secondary - therapy |
1 |
|
adenocarcinoma, follicular - pathology - therapy |
1 |
|
adenocarcinoma, papillary - mortality - pathology - radiotherapy - surgery |
1 |
|
adenocarcinoma, papillary - mortality - pathology - surgery |
1 |
|
adenocarcinoma, papillary - pathology - therapy |
1 |
|
antineoplastic agents - therapeutic use |
1 |
|
antineoplastic combined chemotherapy protocols - toxicity |
1 |
|
ata risk stratification |
1 |
|
biochemical phenomena |
1 |
|
breast cancer |
1 |
|
breast neoplasms - drug therapy - mortality - pathology |
1 |
|
carcinoma - drug therapy - radiotherapy - surgery |
1 |
|
carcinoma - pathology - therapy |
1 |
|
carcinoma, papillary - mortality - pathology |
1 |
|
carcinoma, papillary - mortality - pathology - surgery |
1 |
|
carcinoma, papillary - pathology - secondary - therapy |
1 |
|
cholecalciferol - deficiency |
1 |
|
combined modality therapy |
1 |
|
cushing's syndrome. |
1 |
|
disease recurrence |
1 |
|
disease-free survival |
1 |
|
distant metastasis |
1 |
|
doxorubicin - administration and dosage - analogs and derivatives - therapeutic use - toxicity |
1 |
|
elderly |
1 |
|
electrocautery |
1 |
|
epigastric |
1 |
|
etiology |
1 |
|
goiter, nodular - epidemiology - mortality - pathology - surgery |
1 |
|
hemithyroidectomy |
1 |
|
hernia, ventral - etiology - surgery |
1 |
|
hypercalcemia |
1 |
|
hyperparathyroidism - surgery |
1 |
|
hyperparathyroidism. |
1 |
|
hypocalcemia - etiology |
1 |
|
hypoparathyroidism - complications - radionuclide imaging - surgery |
1 |
|
hypothyroidism |
1 |
|
hypothyroidism - blood - epidemiology - etiology |
1 |
|
indeterminate cytology |
1 |
|
iodine radioisotopes - therapeutic use |
1 |
|
liposomal doxorubicin |
1 |
|
locoregional recurrence |
1 |
|
lymph node excision |
1 |
|
lymphatic metastasis |
1 |
|
lymphovascular invasion |
1 |
|
metastases |
1 |
|
monitoring, intraoperative - methods |
1 |
|
morbidity |
1 |
|
multinodular goiter |
1 |
|
neoplasm invasiveness |
1 |
|
neoplasm invasiveness - pathology |
1 |
|
neoplasm metastasis - drug therapy - pathology |
1 |
|
neoplasm recurrence, local |
1 |
|
neoplasm staging - instrumentation |
1 |
|
neoplasm staging - methods |
1 |
|
papillary thyroid carcinoma (ptc) |
1 |
|
papillary thyroid microcarcinoma (ptmc) |
1 |
|
parathyroid carcinoma |
1 |
|
parathyroid hormone - blood |
1 |
|
parathyroid neoplasms - complications - diagnosis - surgery |
1 |
|
parathyroid neoplasms - surgery |
1 |
|
parathyroidectomy - adverse effects - methods |
1 |
|
parathyroidectomy - methods |
1 |
|
polyethylene glycols - administration and dosage - therapeutic use - toxicity |
1 |
|
postoperative complications - blood - epidemiology |
1 |
|
postoperative complications - diagnosis - etiology - prevention and control |
1 |
|
postoperative complications - epidemiology |
1 |
|
postoperative hypoparathyroidism |
1 |
|
prognosis |
1 |
|
prognostic factors |
1 |
|
radiopharmaceuticals - diagnostic use |
1 |
|
recurrent laryngeal nerve - physiology |
1 |
|
recurrent laryngeal nerve injuries |
1 |
|
recurrent laryngeal nerve injury |
1 |
|
referral and consultation |
1 |
|
reproducibility of results |
1 |
|
statistics, nonparametric |
1 |
|
surgical outcome |
1 |
|
surgical procedures, minimally invasive |
1 |
|
survival |
1 |
|
survival analysis |
1 |
|
survival rate |
1 |
|
technetium tc 99m sestamibi - diagnostic use |
1 |
|
thyroid cancer |
1 |
|
thyroid neoplasm |
1 |
|
thyroid neoplasms - diagnosis |
1 |
|
thyroid neoplasms - drug therapy - radiotherapy - surgery |
1 |
|
thyroid neoplasms - mortality - pathology |
1 |
|
thyroid neoplasms - mortality - pathology - radiotherapy - surgery |
1 |
|
thyroid neoplasms - pathology - surgery |
1 |
|
thyroidectomy - adverse effects - methods |
1 |
|
thyroidectomy - methods |
1 |
|
thyroidectomy - mortality |
1 |
|
thyroiditis |
1 |
|
tnm |
1 |
|
tnm staging |
1 |
|
total thyroidectomy |
1 |
|
ventral hernia |
1 |
|
vinorelbine |
1 |
|
vitamin d deficiency - complications |
1 |
